# Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)

> **NCT01340872** · PHASE3 · COMPLETED · sponsor: **Shield Therapeutics** · enrollment: 128 (actual)

## Conditions studied

- Iron Deficiency Anaemia
- Inflammatory Bowel Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** ST10-021
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01340872
- **Lead sponsor:** Shield Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-10
- **Final completion:** 2014-10
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01340872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01340872, "Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01340872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*